Positive results in Leukemia trials

(Thanks to Atid-EDI) Israel’s BioLineRX announced that its BL-8040 treatment for Chronic Myeloid Leukemia (CML) stopped growth of cancer cells in-vitro and caused them to self-destruct. It also reversed any protection given to the CML cancer cells from a bone marrow transplant.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *